BiotechTube
Kiin Bio

Kiin Bio

London, United Kingdom· Est.
kiin.bio
Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Total funding raised: $5M

Overview

Kiin Bio is an early-stage, private AI-drug discovery company building an integrated platform to automate and accelerate preclinical research. By consolidating a fragmented toolkit landscape into a unified workflow with AI-driven 'Virtual Scientists', the company aims to reduce the time and cost of identifying and validating novel drug candidates. Operating from London, Kiin Bio is positioned in the high-growth intersection of AI and biopharma R&D, targeting partnerships and internal program development. As a pre-revenue platform company, its success hinges on technology validation and securing strategic collaborations or funding.

AI / Machine LearningDrug Discovery

Technology Platform

Unified AI-powered platform integrating 100+ specialized drug discovery tools into a single intelligent workflow, powered by 'Virtual Scientists' to automate and accelerate target identification, compound screening, and lead optimization.

Funding History

1
Total raised:$5M
Seed$5M

Opportunities

The company operates in the high-growth AI drug discovery market, addressing pharma's critical need for R&D efficiency.
Its unified platform approach solves a key integration problem in computational research, creating a potential competitive edge.
Successful validation could lead to lucrative partnerships with large pharma or the development of a valuable internal asset pipeline.

Risk Factors

Key risks include technology validation failure in complex biological systems, intense competition from well-funded AI-biotech peers, and an uncertain path to sustainable revenue.
As a pre-revenue startup, it also faces significant funding and talent retention risks in a competitive market.

Competitive Landscape

Kiin Bio competes in a crowded and well-funded field including pure-play AI biotechs (e.g., Exscientia, Insilico Medicine), large tech entrants (e.g., Google's Isomorphic Labs), and established computational software vendors. Differentiation hinges on the depth of its tool integration, the sophistication of its 'Virtual Scientists,' and its ability to demonstrate superior productivity gains in real-world partnerships.

More companies in United Kingdom →